Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fasting diet may boost recovery after colon cancer surgery

NCT ID NCT05384444

Disease control Sponsor: Fudan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a short-term, low-calorie diet called a fasting mimicking diet (FMD) can help patients recover better after surgery for colorectal cancer. The diet is given in cycles after the operation and is designed to be easier to follow than complete fasting. Researchers will track whether the diet improves survival and reduces cancer recurrence in 602 patients with stage III colorectal cancer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fasting mimicking diet (low-calorie, low-protein meal plan)
What this could lead to
If it works, this diet could become a simple, safe way to improve recovery and reduce cancer recurrence after colorectal cancer surgery.
What could go wrong
This is an early-stage study with no prior data in this specific setting. The diet may not improve outcomes, and some patients may find it hard to follow or experience nutritional side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 602 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2022

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 \~ 80 years old 2. Patients undergoing radical colorectal cancer resection for the first time 3. Preoperative clinical tumor stage III 4. ASA grade I-III grade 5. With BMI 19-32 kg/m2 6. Adequate liver function, adequate renal function and normal cardiac function 7. Willing to participate in the research of the subject and agree to follow up regularly Exclusion Criteria: 1. Evidence of distant metastasis before surgery 2. Before surgery, have received treatment of neoadjuvant chemotherapy 3. Type 1 diabetes or intensive insulin therapy 4. Allergies for FMD content 5. Combined with severe primary diseases such as severe immune system or autoimmune system or long-term using of glucocorticoids or immunosuppressant 6. History of opioid abuse, mental illness or cognitive impairment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer Fasting mimicking diet

Contacts and locations

Locations

  • Fudan University Huashan Hospital

    Shanghai, Shanghai Municipality, 200032, China

  • Fudan University Shanghai Cancer center

    Shanghai, Shanghai Municipality, 200032, China

  • Fudan University,ZhongShan Hospital

    Shanghai, Shanghai Municipality, 200032, China

  • Shanghai Changhai Hospital, Naval Medical University,

    Shanghai, Shanghai Municipality, 200032, China

  • Shanghai First People's Hospital,Shanghai Jiaotong University

    Shanghai, Shanghai Municipality, 200032, China

  • Shanghai Tongji Hospital,Tongji University

    Shanghai, Shanghai Municipality, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.